Back to news

Molina Healthcare Slides as Investors Brace for Earnings and Ongoing Margin Pressure

Investivoq PriceTracker

Molina Healthcare, Inc. (MOH) is down 4.4% today. Here is some analysis on what might have caused this price movement. ([Investivoq.com](https://www.Investivoq.com/news/Molina%2BHealthcare%2Bshares%2Bfall%2Bas%2Binvestors%2Bweigh%2Blingering%2B2026%2Bmargin%2Band%2Bmembership%2Bpressures?utm_source=openai))

Analysis: The most likely driver appears to be investor caution ahead of Molina’s third-quarter 2026 earnings release, combined with lingering concern about Medicaid margin pressure and known 2026 earnings headwinds. This could also reflect continued unease over the profit drag from Molina’s new Florida Medicaid contract and the company’s planned exit from its traditional MAPD product in 2027. ([molinahealthcare.gcs-web.com](https://molinahealthcare.gcs-web.com/news-releases/news-release-details/molina-healthcare-announces-third-quarter-2026-earnings-release?utm_source=openai))

Details:

  • Molina said it will report third-quarter 2026 results after the market close on October 21, 2026, leaving the shares in a wait-for-earnings period. ([molinahealthcare.gcs-web.com](https://molinahealthcare.gcs-web.com/news-releases/news-release-details/molina-healthcare-announces-third-quarter-2026-earnings-release?utm_source=openai))
  • Company guidance for 2026 included a $1.50 per-share burden tied to implementation of the new Florida Medicaid contract. ([investors.molinahealthcare.com](https://investors.molinahealthcare.com/static-files/49cd9252-96dd-4d5f-95ec-ec6957bef433?utm_source=openai))
  • Molina also said underperformance in its traditional Medicare Advantage Part D product would weigh on results by about $1.00 per share, and it plans to exit that product for 2027. ([investors.molinahealthcare.com](https://investors.molinahealthcare.com/static-files/49cd9252-96dd-4d5f-95ec-ec6957bef433?utm_source=openai))
  • Broader managed-care sentiment has remained fragile as investors assess elevated medical costs and pressure on Medicaid profitability across the sector. ([spglobal.com](https://www.spglobal.com/market-intelligence/en/news-insights/articles/2026/7/us-managed-care-stocks-down-following-mixed-cost-heavy-q2-results-104465651?utm_source=openai))

    • Sources:

    Molina Healthcare Investor Relations, SEC, S&P Global

    Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.

    $MOH Insider Trading Activity

    MOH Insider Trades

    $MOH insiders have traded $MOH stock on the open market 2 times in the past 6 months. Of those trades, 0 have been purchases and 2 have been sales.

    Here’s a breakdown of recent trading of $MOH stock by insiders over the last 6 months:

    • JEFF D. BARLOW (Chief Legal Officer) sold 17,811 shares for an estimated $3,314,983
    • MAURICE HEBERT (Chief Accounting Officer) sold 600 shares for an estimated $114,930

    To track insider transactions, check out Investivoq's insider trading dashboard. You can access data on insider stock transactions through the Investivoq API insider transaction endpoint.

    Investivoq Alerts
    Receive MOH Data Alerts
    Get market-moving data, filings, and signals for MOH in real time.
    Sign Up

    $MOH Hedge Fund Activity

    We have seen 317 institutional investors add shares of $MOH stock to their portfolio, and 277 decrease their positions in their most recent quarter.

    Here are some of the largest recent moves:

    • LINGOTTO INVESTMENT MANAGEMENT LLP added 2,511,490 shares (+inf%) to their portfolio in Q2 2026, for an estimated $574,377,763
    • FMR LLC removed 1,333,634 shares (-41.6%) from their portfolio in Q2 2026, for an estimated $305,002,095
    • T. ROWE PRICE INVESTMENT MANAGEMENT, INC. removed 1,154,688 shares (-89.5%) from their portfolio in Q2 2026, for an estimated $264,077,145
    • JANE STREET GROUP, LLC removed 829,536 shares (-99.6%) from their portfolio in Q2 2026, for an estimated $189,714,883
    • AQR CAPITAL MANAGEMENT LLC added 697,208 shares (+24.3%) to their portfolio in Q2 2026, for an estimated $159,451,469
    • MAVERICK CAPITAL LTD removed 645,768 shares (-100.0%) from their portfolio in Q2 2026, for an estimated $147,687,141
    • CAPITAL WORLD INVESTORS removed 636,433 shares (-19.9%) from their portfolio in Q2 2026, for an estimated $145,552,227

    To track hedge funds' stock portfolios, check out Investivoq's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Investivoq API 13F endpoint.

    $MOH Price Targets

    Multiple analysts have issued price targets for $MOH recently. We have seen 9 analysts offer price targets for $MOH in the last 6 months, with a median target of $191.0.

    Here are some recent targets:

    • Andrew Mok from Barclays set a target price of $184.0 on 07/09/2026
    • Ben Hendrix from RBC Capital set a target price of $248.0 on 07/09/2026
    • John Stansel from JP Morgan set a target price of $191.0 on 06/08/2026
    • Erin Wright from Morgan Stanley set a target price of $167.0 on 06/04/2026
    • A.J. Rice from UBS set a target price of $202.0 on 05/22/2026
    • Michael Ha from Baird set a target price of $163.0 on 05/11/2026
    • Sarah James from Cantor Fitzgerald set a target price of $209.0 on 05/11/2026

    This article is not financial advice. See Investivoq's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.